Methylphenidate Modified Released Tablets - Xenidate XL (ADHD) Success

Methylphenidate Modified Release Tablets (Xenidate XL) are used in the management of Attention Deficit Hyperactivity Disorder. They are typically prescribed as part of a comprehensive treatment programme that may include behavioural therapy and educational support.

These tablets contain methylphenidate, a central nervous system stimulant that works by affecting certain chemicals in the brain involved in attention and impulse control. The modified-release formulation allows the medicine to be released gradually, helping to provide symptom control throughout the day.

Xenidate XL should be used under the supervision of a qualified healthcare professional. Dosage is individualised based on patient needs and response to treatment. It should be taken exactly as prescribed, and treatment should not be stopped without medical advice.